LILLIE LENORE 4

4 · KOSS CORP · Filed Feb 3, 2021

Insider Transaction Report

Form 4

Period: 2021-02-01

KOSS CORPKOSS

LILLIE LENORE

VP - Operations

Transactions

Sale
Common Stock
2021-02-01$55.50/sh−12,000$666,000→ 75,088 total
Sale
Common Stock
2021-02-01$48.26/sh−4,000$193,040→ 71,088 total
Exercise/Conversion
Common Stock
2021-02-02$6.00/sh+25,000$150,000→ 35,088 total
Sale
Common Stock
2021-02-02$23.44/sh−1,000$23,440→ 33,088 total
Sale
Common Stock
2021-02-02$18.20/sh−27,500$500,500→ 0 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-01−25,000→ 0 total
Exercise: $4.97Exp: 2022-07-25→ Common Stock (25,000 underlying)
Exercise/Conversion
Common Stock
2021-02-01$5.30/sh+30,000$159,000→ 75,088 total
Exercise/Conversion
Common Stock
2021-02-01$2.57/sh+6,000$15,420→ 81,088 total
Exercise/Conversion
Common Stock
2021-02-01$2.20/sh+1,487$3,271→ 82,575 total
Exercise/Conversion
Common Stock
2021-02-01$2.65/sh+12,000$31,800→ 94,575 total
Sale
Common Stock
2021-02-01$59.54/sh−1,487$88,536→ 93,088 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-01−30,000→ 0 total
Exercise: $5.30Exp: 2023-07-24→ Common Stock (30,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-01−6,000→ 0 total
Exercise: $2.57Exp: 2025-07-29→ Common Stock (6,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-01−12,000→ 18,000 total
Exercise: $2.65Exp: 2028-07-25→ Common Stock (12,000 underlying)
Exercise/Conversion
Common Stock
2021-02-01$4.97/sh+25,000$124,250→ 45,088 total
Sale
Common Stock
2021-02-01$56.36/sh−6,000$338,160→ 87,088 total
Sale
Common Stock
2021-02-01$46.25/sh−6,000$277,500→ 65,088 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-02−25,000→ 0 total
Exercise: $6.00Exp: 2021-07-27→ Common Stock (25,000 underlying)
Sale
Common Stock
2021-02-01$35.54/sh−55,000$1,954,700→ 10,088 total
Sale
Common Stock
2021-02-02$26.97/sh−1,000$26,970→ 34,088 total
Sale
Common Stock
2021-02-02$21.60/sh−3,000$64,800→ 30,088 total
Sale
Common Stock
2021-02-02$19.98/sh−2,588$51,708→ 27,500 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-01−1,487→ 15,000 total
Exercise: $2.20Exp: 2026-07-27→ Common Stock (1,487 underlying)

Holdings

Common Stock
(indirect: ESOP)
30,022

Footnotes (12)

[F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2020.
[F10]This option vests in five equal annual installments beginning on July 27, 2017.
[F11]This option vests in five equal annual installments beginning on July 25, 2019.
[F12]This option vests in five equal annual installments beginning on July 27, 2012.
[F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.98 to $23.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.71 to $20.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.81 to $18.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]This option vests in five equal annual installments beginning on July 25, 2013.
[F8]This option vests in five equal annual installments beginning on July 24, 2014.
[F9]This option vests in five equal annual installments beginning on July 29, 2016.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION